Harvard Bioscience (HBIO) Non-cash Items (2019 - 2024)

Harvard Bioscience (HBIO) has 6 years of Non-cash Items data on file, last reported at $91000.0 in Q2 2024.

• Non-cash Items for Q2 2024 came in at $91000.0, changed N/A year-over-year; the trailing twelve-month figure through Jun 2024 was $91000.0 (changed N/A YoY), and the FY2023 annual result was $1.8 million, up 866.32% from the prior year.
• Non-cash Items eased to $91000.0 in Q2 2024 per HBIO's latest filing, from $964000.0 in the prior quarter.
• Over five years, Non-cash Items peaked at $5.6 million in Q4 2021 and troughed at $91000.0 in Q2 2024.
• A 5-year average of $1.6 million and a median of $913074.5 in 2020 frame the typical range for Non-cash Items.
• The sharpest annual moves came in 2022 and 2023: Non-cash Items plunged 96.58% in 2022, then jumped 866.32% in 2023.
• A 5-year view of Non-cash Items shows it stood at $862149.0 in 2020, then surged by 544.09% to $5.6 million in 2021, then sank by 96.58% to $190000.0 in 2022, then jumped by 866.32% to $1.8 million in 2023, then tumbled by 95.04% to $91000.0 in 2024.
• Business Quant data shows HBIO's Non-cash Items at $91000.0 in Q2 2024, $964000.0 in Q1 2024, and $1.8 million in Q4 2023.